I agree Tb they have definately talked up their expanded cpp library and the automation of scanning. If the library is as big as they say and now over 90% are specifically cell penetrating candidates. Some news on cell specific fpp would certainly be an interesting development as to date their lead fpp seems to be quite non specific (as is tat etc i assume so not neccesarily a bad thing).
Will also be interesting to see if there are any developments on omomyc etc. Who knows maybe we collaborate with Laura Soucek out of the blue maybe as she still seems to be chasing cell penetration.
Ann: Reinstatement to Official Quotation, page-40
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $909.8M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.0¢ | $660.6K | 3.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 22193 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 15000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| PYC (ASX) Chart |